Figure 5.
Effects of MitoQ on biochemical markers of CER-AP. (a) Serum amylase. (b) Pancreatic trypsin activity (normalised to CER-AP group). (c) Pancreatic and (d) lung MPO activity (both normalised to CER-AP group). (e) Serum IL-6 levels. * P < 0.05 when compared with all other groups, †compared with CER-AP group, #compared with MitoQ group at the same dose. Values are the mean ± SEM (n = 6 mice per group).